Medtide Overview
- Year Founded
-
2020
- Status
-
Public
- Employees
-
596
- Stock Symbol
-
03880
- Investments
-
1
- Share Price
-
$2.29
- (As of Friday Closing)
Medtide General Information
Description
Medtide Inc offers full-cycle services ranging from early-stage discovery, preclinical research and clinical development to commercial-stage production. It mainly provide (i) CRO services, namely peptide NCE discovery synthesis; and (ii) CDMO services, namely peptide CMC development and commercial manufacturing. Its services focus on providing customers with APIs rather than drug products. Geographically, the company generates majority of its revenue from USA.
Contact Information
Website
www.medtideinc.comCorporate Office
- No. 69
- No. 12 Street, Qiantang District
- Hangzhou, Zhejiang 310018
- China
Corporate Office
- No. 69
- No. 12 Street, Qiantang District
- Hangzhou, Zhejiang 310018
- China
Medtide Stock Performance
As of 20-Nov-2026, Medtide’s stock price is $2.29. Its current market cap is $481M with 142M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.29 | $2.37 | $2.25 - $3.98 | $481M | 142M | 96.5K | $0.17 |
Medtide Financials Summary
As of 30-Jun-2026, Medtide has a trailing 12-month revenue of $78.7M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 443,251 | 402,214 | ||
| Revenue | 78,721 | 79,274 | 61,630 | 47,601 |
| EBITDA | 28,571 | 35,705 | 13,396 | 12,023 |
| Net Income | 24,159 | 30,227 | 8,247 | 6,912 |
| Total Assets | 274,580 | 259,063 | 160,632 | 184,627 |
| Total Debt | 4,493 | 4,395 | 5,636 | 45,544 |
Medtide Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Medtide Signals
Medtide Acquisitions (1)
Medtide’s most recent deal was a Merger/Acquisition with CPC Scientific for . The deal was made on 01-Jan-2015.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CPC Scientific | 01-Jan-2015 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology |
Medtide ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Medtide Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| CPC Scientific | Rocklin, CA | 2001 |
Medtide FAQs
-
When was Medtide founded?
Medtide was founded in 2020.
-
Where is Medtide headquartered?
Medtide is headquartered in Hangzhou, China.
-
What is the size of Medtide?
Medtide has 596 total employees.
-
What industry is Medtide in?
Medtide’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Medtide a private or public company?
Medtide is a Public company.
-
What is Medtide’s stock symbol?
The ticker symbol for Medtide is 03880.
-
What is the current stock price of Medtide?
As of 20-Nov-2026 the stock price of Medtide is $2.29.
-
What is the current market cap of Medtide?
The current market capitalization of Medtide is $481M.
-
What is Medtide’s current revenue?
The trailing twelve month revenue for Medtide is $78.7M.
-
What is Medtide’s annual earnings per share (EPS)?
Medtide’s EPS for 12 months was $0.17.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process